The 2024 Gold Rush: Unleashing Market Potential

Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.

Get your free information kit NOW, before it's too late.

LGND Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.40%

Insider Buying (Last 12 Months): $237,520.00

Insider Selling (Last 12 Months): $990,360.14

Ligand Pharmaceuticals Insider Trading History Chart

Ligand Pharmaceuticals Share Price & Price History

^$80.36

▲ +7.14 (9.75%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Ligand Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2024	Stephen L Sabba	Director	Sell	1,893	$74.30	$140,649.90	28,926
2/28/2024	Octavio Espinoza	CFO	Sell	140	$88.46	$12,384.40	29,755
9/22/2023	Todd C Davis	CEO	Buy	4,000	$59.38	$237,520.00	73,090
5/16/2023	John W Kozarich	Director	Sell	4,444	$77.20	$343,076.80	38,488
5/10/2023	Stephen L Sabba	Director	Sell	6,408	$77.13	$494,249.04	25,784
5/8/2023	John W Kozarich	Director	Sell	6,408	$76.56	$490,596.48	42,213
3/24/2023	Andrew Reardon	Insider	Sell	300	$69.92	$20,976.00	16,308
12/16/2022	John L. Higgins	Director	Sell	10,000	$61.87	$618,700.00	422,984
11/17/2022	John L. Higgins	CEO	Sell	10,000	$78.32	$783,200.00	416,731
11/9/2022	Octavio Espinoza	CFO	Sell	1,696	$75.64	$128,285.44	8,857
9/15/2022	John L. Higgins	CEO	Sell	2,000	$90.00	$180,000.00	367,180
5/13/2022	Matthew W. Foehr	COO	Buy	2,500	$82.76	$206,900.00	173,354
2/28/2022	John W Kozarich	Director	Sell	908	$102.62	$93,178.96
11/12/2021	John L. Higgins	CEO	Sell	3,000	$160.50	$481,500.00
11/11/2021	Matthew W. Foehr	COO	Sell	11,160	$163.02	$1,819,303.20
8/4/2021	Matthew W. Foehr	COO	Sell	8,840	$109.67	$969,482.80	173,195

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

91.28% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ligand Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/9/2024	State Board of Administration of Florida Retirement System	4,070	$0.30M	0.0%	-14.5%	0.023%
5/8/2024	Everence Capital Management Inc.	2,760	$0.20M	0.0%	N/A	0.016%
5/8/2024	William Blair Investment Management LLC	189,247	$13.83M	0.0%	+1.0%	1.069%
5/8/2024	ProShare Advisors LLC	4,627	$0.34M	0.0%	+8.5%	0.026%
5/8/2024	Isthmus Partners LLC	48,331	$3.53M	0.4%	+40.7%	0.273%
5/8/2024	Russell Investments Group Ltd.	73,161	$5.35M	0.0%	+155.3%	0.413%
5/8/2024	Headlands Technologies LLC	623	$46K	0.0%	-35.4%	0.004%
5/7/2024	Sei Investments Co.	35,841	$2.62M	0.0%	+224.1%	0.202%
5/7/2024	Swiss National Bank	32,700	$2.39M	0.0%	+0.6%	0.185%
5/7/2024	Illinois Municipal Retirement Fund	10,158	$0.74M	0.0%	+8.4%	0.057%
5/7/2024	SG Americas Securities LLC	11,061	$0.81M	0.0%	N/A	0.062%
5/6/2024	Texas Permanent School Fund Corp	14,344	$1.05M	0.0%	+1.3%	0.081%
5/2/2024	Nordea Investment Management AB	68,328	$4.94M	0.0%	-0.9%	0.386%
5/1/2024	BNP Paribas Financial Markets	9,296	$0.68M	0.0%	-49.7%	0.053%
4/29/2024	Principal Financial Group Inc.	92,124	$6.73M	0.0%	-0.7%	0.520%
4/29/2024	China Universal Asset Management Co. Ltd.	3,437	$0.25M	0.0%	+70.8%	0.019%
4/26/2024	Yousif Capital Management LLC	7,446	$0.54M	0.0%	-9.1%	0.042%
4/25/2024	Villere ST Denis J & Co. LLC	490,752	$35.87M	2.9%	+14.6%	2.773%
4/23/2024	Rice Hall James & Associates LLC	279,784	$20.45M	1.2%	+1.4%	1.581%
4/23/2024	KLR Investment Advisors LLC	4,497	$0.31M	0.2%	N/A	0.025%
4/19/2024	AMI Asset Management Corp	40,931	$2.99M	0.2%	-4.0%	0.231%
4/18/2024	Allspring Global Investments Holdings LLC	85,195	$6.23M	0.0%	+129.2%	0.481%
4/11/2024	BTC Capital Management Inc.	4,605	$0.34M	0.0%	N/A	0.026%
4/2/2024	M&R Capital Management Inc.	2,000	$0.15M	0.0%	N/A	0.011%
3/22/2024	PNC Financial Services Group Inc.	1,840	$0.13M	0.0%	+32.4%	0.010%
3/11/2024	Vanguard Group Inc.	1,876,514	$134.02M	0.0%	+1.3%	10.602%
3/5/2024	Fisher Asset Management LLC	49,297	$3.52M	0.0%	+48.2%	0.279%
2/22/2024	Scarborough Advisors LLC	1,502	$0.11M	0.0%	N/A	0.009%
2/16/2024	Spouting Rock Asset Management LLC	3,445	$0.25M	0.1%	-62.6%	0.020%
2/13/2024	Stephens Investment Management Group LLC	659,434	$47.10M	0.7%	+41.0%	3.801%
2/13/2024	Campbell & CO Investment Adviser LLC	7,581	$0.54M	0.0%	+47.3%	0.044%
2/12/2024	Isthmus Partners LLC	34,347	$2.45M	0.3%	+4.7%	0.198%
2/9/2024	Franklin Resources Inc.	14,066	$1.01M	0.0%	+3.2%	0.081%
2/9/2024	GW&K Investment Management LLC	55,335	$3.95M	0.0%	+47.8%	0.319%
2/9/2024	Hillsdale Investment Management Inc.	41,532	$2.97M	0.2%	-12.8%	0.239%
2/9/2024	Norges Bank	107,188	$7.66M	0.0%	N/A	0.618%
2/8/2024	Brown Advisory Inc.	7,757	$0.55M	0.0%	N/A	0.045%
2/7/2024	Principal Financial Group Inc.	92,810	$6.63M	0.0%	-1.3%	0.535%
2/7/2024	Dimensional Fund Advisors LP	661,298	$47.23M	0.0%	+7.6%	3.812%
2/7/2024	BNP Paribas Financial Markets	18,482	$1.32M	0.0%	-11.1%	0.107%
2/7/2024	Teacher Retirement System of Texas	3,814	$0.27M	0.0%	-18.0%	0.022%
2/7/2024	Versor Investments LP	3,848	$0.28M	0.1%	-23.8%	0.022%
2/7/2024	Principal Securities Inc.	747	$53K	0.0%	N/A	0.004%
2/6/2024	Charles Schwab Investment Management Inc.	161,480	$11.53M	0.0%	+2.7%	0.931%
2/6/2024	Amalgamated Bank	6,294	$0.45M	0.0%	-2.4%	0.036%
2/6/2024	Summit Global Investments	19,397	$1.39M	0.1%	-12.2%	0.112%
2/6/2024	Swiss National Bank	32,500	$2.32M	0.0%	-10.0%	0.187%
2/6/2024	Fisher Asset Management LLC	49,297	$3.52M	0.0%	+48.2%	0.284%
2/5/2024	Victory Capital Management Inc.	21,385	$1.53M	0.0%	+22.8%	0.123%
2/5/2024	Russell Investments Group Ltd.	28,662	$2.05M	0.0%	+65.5%	0.165%
2/2/2024	Headlands Technologies LLC	964	$69K	0.0%	-29.8%	0.006%
2/2/2024	Cornerstone Capital Inc.	6,957	$0.50M	0.1%	-7.3%	0.040%
2/2/2024	Acuitas Investments LLC	47,703	$3.41M	1.7%	N/A	0.275%
2/1/2024	Linden Thomas Advisory Services LLC	16,393	$1.17M	0.2%	-2.3%	0.094%
2/1/2024	New York State Common Retirement Fund	7,200	$0.51M	0.0%	-7.4%	0.041%
2/1/2024	Illinois Municipal Retirement Fund	9,368	$0.67M	0.0%	-2.0%	0.054%
2/1/2024	Cetera Trust Company N.A	2,205	$0.16M	0.1%	N/A	0.013%
1/31/2024	abrdn plc	290,418	$20.74M	0.0%	-9.3%	1.674%
1/31/2024	Calamos Advisors LLC	4,586	$0.33M	0.0%	N/A	0.026%
1/31/2024	Federated Hermes Inc.	38,964	$2.78M	0.0%	-20.5%	0.225%
1/30/2024	Strs Ohio	11,000	$0.79M	0.0%	-2.7%	0.063%
1/29/2024	Louisiana State Employees Retirement System	8,200	$0.59M	0.0%	N/A	0.047%
1/29/2024	Smith Graham & Co. Investment Advisors LP	83,121	$5.94M	0.7%	+34.4%	0.479%
1/26/2024	Mutual of America Capital Management LLC	2,869	$0.21M	0.0%	N/A	0.017%
1/26/2024	Impax Asset Management Group plc	205,208	$14.66M	0.1%	+11.3%	1.183%
1/25/2024	Allspring Global Investments Holdings LLC	37,173	$2.66M	0.0%	+98.8%	0.214%
1/25/2024	International Assets Investment Management LLC	5,785	$0.41M	0.0%	N/A	0.033%
1/25/2024	Villere ST Denis J & Co. LLC	428,051	$30.57M	2.5%	-2.3%	2.467%
1/24/2024	International Assets Investment Management LLC	5,785	$0.41M	0.0%	N/A	0.033%
1/24/2024	China Universal Asset Management Co. Ltd.	2,012	$0.14M	0.0%	+356.2%	0.012%
1/22/2024	Chicago Capital LLC	231,511	$16.54M	0.6%	-35.8%	1.334%
1/19/2024	AMI Asset Management Corp	42,619	$3.04M	0.2%	+25.6%	0.246%
1/16/2024	Pacer Advisors Inc.	325,727	$23.26M	0.1%	+59.1%	1.877%
1/16/2024	Legato Capital Management LLC	2,975	$0.21M	0.0%	N/A	0.017%
1/12/2024	Advisor Resource Council	2,804	$0.20M	0.0%	N/A	0.016%
1/11/2024	Ziegler Capital Management LLC	50,423	$3.60M	0.2%	-59.1%	0.291%
1/10/2024	Nordea Investment Management AB	68,971	$4.93M	0.0%	-3.3%	0.398%
1/8/2024	Woodstock Corp	30,111	$2.15M	0.2%	-11.9%	0.174%
12/18/2023	Vanguard Group Inc.	1,851,861	$110.96M	0.0%	-0.1%	10.670%
12/6/2023	Citigroup Inc.	8,777	$0.53M	0.0%	-45.4%	0.051%
11/24/2023	Deutsche Bank AG	136,229	$8.16M	0.0%	+43.0%	0.785%
11/15/2023	Kennedy Capital Management LLC	35,699	$2.14M	0.1%	+3.5%	0.206%
11/14/2023	Gotham Asset Management LLC	7,483	$0.45M	0.0%	-19.4%	0.043%
11/14/2023	Qube Research & Technologies Ltd	40,254	$2.41M	0.0%	+157.3%	0.232%
11/13/2023	Federated Hermes Inc.	49,024	$2.94M	0.0%	-0.5%	0.283%
11/13/2023	Invesco Ltd.	218,787	$13.11M	0.0%	-1.4%	1.261%
11/13/2023	Nordea Investment Management AB	71,352	$4.39M	0.0%	-1.1%	0.411%
11/13/2023	DekaBank Deutsche Girozentrale	11,185	$0.69M	0.0%	+11.9%	0.064%
11/9/2023	William Blair Investment Management LLC	159,793	$9.58M	0.0%	+3.2%	0.921%
11/9/2023	Rhumbline Advisers	57,127	$3.42M	0.0%	+2.9%	0.329%
11/9/2023	Deutsche Bank AG	136,229	$8.16M	0.0%	+43.0%	0.785%
11/9/2023	Citigroup Inc.	8,777	$0.53M	0.0%	-45.4%	0.051%
11/9/2023	Skandinaviska Enskilda Banken AB publ	18,000	$1.08M	0.0%	+8.4%	0.104%
11/9/2023	Headlands Technologies LLC	1,373	$82K	0.0%	-14.9%	0.008%
11/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	10,907	$0.65M	0.0%	-41.2%	0.063%
11/9/2023	Texas Permanent School Fund Corp	13,855	$0.83M	0.0%	-4.1%	0.080%
11/8/2023	Campbell & CO Investment Adviser LLC	5,146	$0.31M	0.0%	+13.6%	0.030%
11/8/2023	HighTower Advisors LLC	4,567	$0.28M	0.0%	+57.9%	0.026%
11/8/2023	Charles Schwab Investment Management Inc.	157,187	$9.42M	0.0%	+1.8%	0.906%
11/8/2023	Swiss National Bank	36,100	$2.16M	0.0%	+2.3%	0.208%

Data available starting January 2016

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Filspari, a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression; and Veklury, an antiviral treatment for moderate or severe COVID-19. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in Jupiter, Florida.

Today's Range

Now: $80.36

$72.95

$81.38

50 Day Range

MA: $74.10

$68.53

$81.50

52 Week Range

Now: $80.36

$49.24

$94.57

Volume

286,949 shs

Average Volume

158,328 shs

Market Capitalization

$1.42 billion

P/E Ratio

29.22

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top insider investors include:
John L Higgins (Director)
John L Higgins (CEO)
Matthew W Foehr (COO)
Todd C Davis (CEO)
John W Kozarich (Director)
Octavio Espinoza (CFO)
Stephen L Sabba (Director)
Andrew Reardon (Insider)
Learn More about top insider investors at Ligand Pharmaceuticals.
Who are the major institutional investors of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top institutional investors include:
Villere ST Denis J & Co. LLC — 2.77%
Rice Hall James & Associates LLC — 1.58%
William Blair Investment Management LLC — 1.07%
Principal Financial Group Inc. — 0.52%
Allspring Global Investments Holdings LLC — 0.48%
Russell Investments Group Ltd. — 0.41%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.
Which institutional investors are selling Ligand Pharmaceuticals stock?: In the previous quarter, LGND stock was sold by these institutional investors:
BNP Paribas Financial Markets
AMI Asset Management Corp
Yousif Capital Management LLC
State Board of Administration of Florida Retirement System
Principal Financial Group Inc.
Nordea Investment Management AB
Headlands Technologies LLC
During the previous year, company insiders that have sold Ligand Pharmaceuticals company stock include:
John L Higgins (Director)
John L Higgins (CEO)
Matthew W Foehr (COO)
Learn More investors selling Ligand Pharmaceuticals stock.
Which institutional investors are buying Ligand Pharmaceuticals stock?: During the previous quarter, LGND stock was acquired by institutional investors including:
Villere ST Denis J & Co. LLC
Allspring Global Investments Holdings LLC
Russell Investments Group Ltd.
Sei Investments Co.
Isthmus Partners LLC
SG Americas Securities LLC
BTC Capital Management Inc.
KLR Investment Advisors LLC
Within the last year, these company insiders have bought Ligand Pharmaceuticals stock:
John L Higgins (Director)
John L Higgins (CEO)
Learn More investors buying Ligand Pharmaceuticals stock.